• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1994 Fiscal Year Final Research Report Summary

Virological features of hepatitis C virus infection in patients with liver diseases in a high risk region for hepatocellular carcinoma in China

Research Project

Project/Area Number 05670480
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Gastroenterology
Research InstitutionUniversity of Tokushima

Principal Investigator

ITO Susumu  University of Tokushima, School of Medicine, Professor, 医学部, 教授 (70093838)

Co-Investigator(Kenkyū-buntansha) SHIMIZU Ichiro  University of Tokushima, University Hospital, Instructor, 医学部・附属病院, 講師 (10178965)
Project Period (FY) 1993 – 1994
Keywordshepatitis C virus / hepatocellular carcinoma / molecular biology / anti-HCV / HCV-RNA / China
Research Abstract

Hepatitis C virus (HCV) is an important causative agent for hepatocellular carcinoma (HCC) in Western countries and Japan. On the other hand, the inshore area of the Yangtze River is known to have one of the highest incidences of HCC in China. Therefore, to obtain information on the association between HCC and the genomic characteristics of HCV isolates present in this region, we investigated the prevalence and the genomic heterogeneity of HCV in patients with chronic liver disease and HCC in this region. Most of such patients were infected by hepatitis B virus (HBV), but the incidence of anti-HCV and HCV-RNA were very low, observed with 0.7% in donor bloods, and 11.6% in patients with chronic liver diseases. Moreover, our results reveraled a high prevalence of genotype II,a genotype II,a similarity of Chinese and Japanses HCV isolates, and a tendency for more nucleotide (nt) substitutions in the HCV core gene in HCC patients than in those substitutions in the HCV core gene in HCC patients than in those with chronic hepatitis. In addition, nt substitutions were unevenly scattered along the genome with a cluster of missense mutations and transversions in the second hydrophilic domain from the 5'end of the core region. The rates of the occurrence of missense mutations and transversions were greater in the clustering variable region (CVR) than in the other core region. These findings suggested that the mutations occurring in this CVR may be responsible for a selective pressure from the host immune system, and closely related with progress of liver disease to HCC.

  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] Ito S: "Epidemiological characteristics of the incidence of hepatitis C virus(C100-3)antibodies in patients with liver diseases in the inshore area of the Yangtze river." J.Gastroenterol.Hepatology. 8. 232-237 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ito S: "HCV infection and its clinical features in recipients of blood screened for HCV(C100-3)antibody." J.Gastroenterol.Hepatology. 9. 19-25 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Honda H: "Prevalence of HCV-antibodies and HCV-RNA in donor blood in Tokushima prefecture." Tokushima J.Exp.Med.41. 9-15 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yao D-F: "Virological features of hepatitis C virus infection in patients with liver diseases in the inshore area of the Yangtze River." Tokushima J.Exp.Med.41. 49-56 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ito S: "Incidences of hepatitis C virus(HCV)antibodies and HCV-RNA in blood donors and patients with liver diseases in the inshore area of the Yangtze river." J.Gastroenterol.Hepatology. 9. 245-249 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Horikita M: "Differences in the entire nucleotide sequence between hepatitis B virus genomes from carriers positive for antibody to hepatitis B e antigen with and without active disease" J.Med.Virol.44. 96-103 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 本田浩仁: "HCV(C100-3)抗体スクリーニング後の輸血例におけるHCV感染状況と病態に関する研究" 肝臓. 34. 105-113 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 日比野真吾: "HCV(C100-3)抗体スクリーニング後の輸血後肝炎および同疑診例の感染源に関する検討." 日輸血会誌. 39. 814-823 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 本田浩仁: "輸血用血液におけるHCV(C100-3)抗体スクリーニングの効果-第二世代検査法とHCV-RNA測定による評価-." 日輸血会誌. 39. 853-859 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 堀江千昌: "揚子江下流域肝癌多発地区における肝疾患の特性とHCVに関する研究" 肝臓. 36(2). 100-108 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ito S: "Epidemiological characteristics of the incidence of hepatitis C virus (C100-3) antibodies in patients with liver diseases in the inshore area of the Yangtze River." J Gastroenterol Hepatol. 8. 232-237 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ito S: "HCV infection and its clinical features in recipients of blood screened for HCV (C100-3) antibody." J Gastroenterol Hepatol. 9. 19-25 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ito S: "Incidence of hepatitis C virus (HCV) antibodies and HCV-RNA in blood donors and patients with liver diseases in the inshore area of the Yangtze River." J Gastroenterol Hepatol. 3. 245-249 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Honda H: "Prevalance of HCV-antibodies and HCV-RNA in donor blood in Tokushima prefecture" Tokushima J Exp Med. 41. 9-15 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yao D-F: "Virological features of hepatitis C virus infection in patients with liver diseases in the inshore area of the Yangtze River" Tokushima J Exp Med. 41. 49-56 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Horikita M: "Differences in the entire nucleotide sequence between hepatitis V virus genome from carriers positive for antibody to hepatitis B e antigen with and without active disease." J Med Virol. 44. 96-103 (1994)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1996-04-15  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi